...Going uP!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Suti BoOm coming!!
Nice chart for SING!
VCPS 243mil float @.0005!!!
LoW FLOAT: VCPS 243mil @.0005!!!
It was a good day today! Looking forward to tomorrow and the next few weeks imo! Now is when the real fun starts here on INMG..
500mil BID on dECk!! NEWS Tomorrow or very soon??? SUTI
BooM! INMG $$$$$$$
Maybe when you stop looking at it or reloading it yourself SUTI
The gov in state of Wyoming is NOT a scam..
https://wyobiz.wy.gov/business/FilingDetails.aspx?eFNum=069167253069047076105039056075216227040057012139
2s are getting chewed up! Bye bye 2s suti
WoW! Bid is growing / Ask is shrinking! Fastt SUTI
O/S 261,896,775 a/o Jul 31, 2017
Float 243,896,775 a/o Jul 31, 2017
This is what im waiting for.....
We are on schedule to have a formal update later in the year from the Patent Trademark Office, as which time we determine to best strategy of filing for additional Patents applications that we have developed or possible alternative uses for the IP. The major refresh of our website and apps (iOS and Android) is nearing completion and it will provide our customers alternative member authentication such as LinkedIn, updated and broader content coverage.
MJAC has been adding new speakers weekly! More eyes on INMG $$$$$$$
Good morning INMG !! MJAC is around the corner.! Let's make this week count!! $$$$$$$
Very smart move AK! Good luck to us longs and safe travels!!
I just got back from the beach, and excitingly open up ihub for INMG! Read a few post and thought, the INMG Crew shouldn't be acting or feeling this way.. we are pretty much a team here and we all have the same agenda. INMG succeeds and we all succeed.. That being said, let's get back on a good positive note here and focus more on INMG as a group instead of anyone of us individuals... I'd like to start... I'm excited that MJAC 2017 is 11 days away!! 2500+ INVESTORS (<~~ key word ) are going to be looking at INMG ! How great is that!! Has anyone noticed key points, please point them out!! Much appreciated!!!
I have a question in regards to INMG shareholders.. Do you know what you own?
Listen Board! INMG is one of best tickers in the otc, imo btw.. And don't care what anybody else thinks about my opinion. I am greatful for all the DD everyone has offered. Good or Bad info thank you! But just one request.. let's play nice. Positive feels better than nagative..
Keep it INMG!
Up she goes!! GO SING
Good! More shares in stronger hands! INMG
Good deal Bod.. I myself wish I can dedicate ALL my time to INMG as well.. but life sometimes doesn't let us.. For example: I need to go to the potty right now and can't bring my monitor with me !! :D lol. Personally, I believe we have a lot of good people here and I'm not worried about my investment either. GLTU INMG LONGS!
Revenues increased by 489% to $882,353 in the second quarter of 2017
Medicine Man Technologies Reports Second Quarter 2017 Results
GlobeNewswire
4:36 PM ET
Medicine Man Technologies Inc. (OTCQB: MDCL), one of the United States' leading cannabis branding and consulting companies, reported financial results for the quarter ended June 30, 2017.
Financial and Business Highlights:
-- Revenues increased by 489% to $882,353 in the second quarter of 2017, from $149,766 in the corresponding period in 2016, driven by higher consulting-based revenues and the contribution of the newly acquired Pono Publications and Success Nutrient businesses
-- The acquisitions of Pono Publications and Success Nutrients provide industry leading cannabis cultivation technologies and products. These businesses generated $352,158 of revenue in the second quarter of 2017, providing full-quarter contributions to Company revenue
-- Brett Roper named as Chief Executive Officer at the first annual shareholders meeting, replacing Andrew Williams who assumed Brett Roper's prior role as Chairperson of the Board of Directors
-- Named recognized cannabis cultivation expert, Joshua Haupt, as Chief Cultivation Officer
-- The Company experienced extraordinary one-time expenses related to acquisition costs and stock compensation totaling $4,579,019, which accounted for more than the entire net loss in the second quarter of 2017
-- Subsequent to the end of the second quarter, Medicine Man completed the acquisition of Denver Consulting Group in July 2017
-- Demand for services and recent acquisitions have allowed our Company to grow from 5 full time and 2 part time positions at year end 2016 to 19 full time and 2 part time positions as of this date
-- We have increased our Board of Directors to five persons, three of which are independent and held our first annual shareholder meeting in Denver on June 3, 2017
"We are pleased with our second quarter results, which reflect the integration of Pono Publications, led by its flagship the Three A Light(TM) publication and Success Nutrients into Medicine Man Technologies," commented Brett Roper, Chief Executive Officer of the Company. "We view these acquisitions as transformatio nal, as not only do these businesses provide the Company with industry leading cultivation methodologies that we are already leveraging across our broad range of product and consulting services offerings, but also bring Joshua Haupt, their founder and a world-renowned cannabis cultivation thought leader, to Medicine Man Technologies as our Chief Cultivation Officer. We look forward to continuing to execute on our Brand Warehouse acquisition strategy, seeking synergistic companies across the cannabis industry that can support our U.S. and international expansion plan," concluded Mr. Roper.
Business Highlights
During the second quarter of 2017, Medicine Man added 13 new clients, spanning the states of Florida, Arkansas, Ohio, Michigan, Nevada, and California. Subsequent to the end of the quarter, the Company added one Ohio based processing application group, three Arkansas based dispensary application groups, two Florida based application groups, and two Michigan cultivation/processor application group, and one Canadian cultivation entity bringing our total active clients number (including DCG Legacy Clients) up to 44. Revenue generation for the Company is expected to run through the entirety of the general application process as determined by each state.
The initial Cultivation Max harvest clients in Nevada are expected later in the third quarter of 2017, from which Medicine Man expects to earn init ial revenues beginning in the fourth quarter of this year.
The Company remains encouraged by the prospects for rapid expansion of its product and service footprint resulting from recent acquisitions. Medicine Man continues to experience a robust pace of inquiries on the west coast and elsewhere in the United States for its services, driven by its Denver Consulting Group division, the Company's internal marketing and event presence, and its Three A Light publication and Success Nutrients business presence.
Results of Operations for the three months ended June 30, 2017 and 2016
During the three months ended June 30, 2017, Medicine Man generated revenues of $882,353, which represented an increase of 489% over the same period in 2016. Second quarter 2017 revenue consisted of consulting/licensing fees of $527,895, product sales of $352,158 and the balance from fees arising from our participation in cannabis seminars. In the three months ended June 30, 2016, revenue totaled $149,766, consisting of $142,986 from consulting/licensing fees, and the balance from seminars.
Cost of services, consisting of expense related to delivery of services and product procurement, was $272,001 during the three months ended June 30, 20 17, compared to $44,177 during the comparable period in 2016, with the increase largely attributable to the addition of product procurement expenses and increases in wages. The Company notes that during the second quarter of 2017, Medicine Man had eight full-time and two part-time employees, as compared to three full-time and two part-time employees in the second quarter of 2016.
Operating expenses during the three months ended June 30, 2017, were $5,172,869, including a one-time stock compensation expense of $4,480,318, compared with $207,059 in the corresponding period in 2016. General and administrative expense in the three months ended June 30, 2017 totaled $331,425, compared to $197,879 during the three months ended June 30, 2016. Increased operating expenses during the three months ended J une 30, 2017 included professional fees of $141,953 and advertising expense of $56,025. Advertising expense during the three months ended June 30, 2016 totaled $9,180. During the three months ended June 30, 2017, the Company incurred $98,701 in one-time acquisition costs related to the Pono and Success acquisitions.
Net loss for the three months ended June 30, 2017 was $4,494,435, or $0.23 per share, compared to net loss of $99,662, or $0.01 per share, during the three months ended June 30, 2016, primarily due to one-time costs related to stock compensation.
Results of Operations for the six months ended Jun e 30, 2017 and 2016
During the six months ended June 30, 2017, we generated revenues of $1,423,489, which represented an increase of 307% over the same period in 2016. Six-month 2017 revenue consisted of consulting/licensing fees of $1,067,109, product sales of $352,158 and the balance of fees arising from our participation in cannabis seminars. In the six months ended June 30, 2016 revenue totaled $349,381, consisting of $337,221 from consulting/licensing fees, and the balance from seminars. This increase was due to the acquisition of Pono and Success, growth in our service model and growth within our client base.
Cost of services, consisting of expense related to delivery of services and product procurement, was $437,160 during the six months ended June 30, 2017, compared to $181,618 during the comparable period in 2016, with the increase largely attributable to the addition of product procurement expenses and increases in wages from an expanded employee base, as discussed earlier.
Operating expenses during the six months ended June 30, 2017, were $5,401,754, including a one-time stock compensation expense of $4,480,318. General and administrative expense were $435,296, compared to $312,217 during the six months ended June 30, 2016. Increased operating expenses during the six months ended June 30, 2017 included additional cost incurred related to professional fees of $233,483, as well as $89,509 in advertising expense, compared to advertising expenses of $21,672 during the same period in 2016. The Company has increased its investment substantially in the Marijuana Business Daily conference offerings as well as publication platform based upon their continued growth in popularity and prospect generation capacities. During the six months ended June 30, 2017, the Company incurred $98,701 in one-time acquisition costs related to the Pono and Success acquisition.
Net loss during the six months ended June 30, 2017 totaled $4,383,271, or $0.22 per share, compared to net loss of $213,518, or $0.02 per share, for the six months ended June 30, 2016, with the increase primarily driven by one-time stock-based compensation costs, as discussed above.
At June 30, 2017, the Company reported cash and cash equivalents of $200,600, compared with $351,524 at December 31, 2016. At June 30, 2017, receivables were $231,399, compared with $25,000 at June 30, 2016, with the increase attributable to collections of earned income that were due near the end of the quarter, that have been fully collected subsequent to the end of the quarter.
About Medicine Man Technologies, Inc.
Established in March 2014, the Company secured its fir st client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. It currently has twenty eight active clients in 12 states and Puerto Rico, focusing on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company's highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will 'share' the ever-improving experience and knowledge of the network, and 5) continuing the expansion of its Brands Warehouse concept.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Excha nge Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based upon many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be pr oviding services, the impact of which cannot be predicted at this time.
MEDICINE MAN TECHNOLOGIES, INC.
STATEMENT OF COMPREHENSIVE (LOSS) AND INCOME
For the Three and Six Months Ended June 30, 2017 and 2016
Express in U.S. Dollars < br xmlns:ms="urn:schemas-microsoft-com:xslt" xmlns:dt="urn:schemas-microsoft-com:datatypes" />
Three Months Ended June 30, Six Months Ended June, 30 2017 2016 2017 2016 Operating revenues Product sales $ 229,214 $ - $ 229,214 $ - Product sales - related party 122,944 - 122,944 - Licensing fees 301,313 142,986 501,313 337,221 Consulting fees 226,582 - 565,796 $ - Seminar fees 2,300 6,780 4,222 12,160 Total revenue 882,353 149,766 1,423,489 349,381 Cost of services Cost of services $ 245,965 $ 44,177 $ 411,124 $ 181,618 Cost of services - related party 26,036 - 26,036 - Total cost of services 272,001 44,177 437,160 181,618 Gross profit $ 610,352 $ 105,589 $ 986,329 $ 167,763 Operating expenses General and administrative $ 331,425 $ 197,879 $ 435,296 $ 312,217 Professional services 141,953 - 233,483 - One-time Acquisition costs 98,701 - 98,701 - Stock based compensation expense 4,480,318 - 4,480,318 49,200 Advertising 56,025 9,180 89,509 21,672 Salaries 64,447 - 64,447 - Total operating expenses $ 5,172,869 $ 207,059 $ 5,401,754 $ 383,089 Income from operations $ (4,562,517 ) $ (101,470 ) $ (4,415,425 ) $ (215,326 ) Other income/expense Interest income $ (7,480 ) $ (1,808 ) $ (14,877 ) $ (1,808 ) Net gain on derivative (82,373 ) - (131,382 ) - Interest expense related to convertible notes 21,990 - 44,329 - Loss on management fee contracts - - 70,257 - Net unrealized (loss) on available for sale securities - - (262 ) - Other income (219 ) - (219 ) - Total other expense (68,082 ) (1,808 ) (32,154 ) (1,808 ) Net income (loss) $ (4,494,435 ) $ (99,662 ) $ (4,383,271 ) $ (213,518 ) Earnings per share attributable to common shareholders: Basic and diluted (loss)/earnings per share $ (0.23 ) $ (0.01 ) $ (0.22 ) $ (0.02 ) Weighted average number of shares outstanding - basic and diluted 19,548,087 10,092,500 19,548,087 10,031,875 Other comprehensive income (loss), net of tax Net unrealized (loss) on available for sale securities (9,248 ) (16,000 ) (10,551 ) (5,600 ) Total other comprehensive income (loss), net of tax (9,248 ) (16,000 ) (10,551 ) (5,600 ) Comprehensive gain (loss) $ (4,503,683 ) $ (115,662 ) $ (4,393,822 ) $ (219,118 ) MEDICINE MAN TECHNOLOGIES, INC.
BALANCE SHEETS
Express in U.S. Dollars
June 30, 2017 December 31, 2016 Assets Current assets Cash and cash equivalents $ 200,600 $ 351,524 Accounts receivable, net 231,399 25,000 Accounts receivable - related party 24,294 - Available for sale securities 17,701 13,998 Short-term note receivable 278,893 264,016 Inventory 109,174 - Other assets 50,006 27,479 Total current assets 912,067 682,017 Non-current assets Fixed assets, net accumulated depreciation of $46,278 $ 154,033 $ 42,126 Intangible assets, net accumulated amortization of $3,055 72,869 3,708 Goodwill 6,301,080 - Total non-current assets 6,527,982 45,834 Total assets $ 7,440,049 $ 727,851 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 32,328 $ - Derivative liability 23,017 294,002 Other liabil ities 10,713 175 Total current liabilities 66,058 294,177 Long-term liabilities Note payable - related party $ 58,280 $ - Convertible loan 675,000 810,000 Total long-term liabilities 733,280 810,000 Total liabilities 799,338 1,104,177 Commitments and contingencies, note 13 Shareholders' equity Common stock $0.001 par value, 90,000,000 authorized, 18,948,087 and 10,402,500 were issued and outstanding June 30, 2017 and December 31, 2016, respectively $ 19,118 $ 10,403 Additional paid-in capital 10,327,876 1,026,052 Additional paid-in capital - Warrants 2,100,318 - Accumulated other comprehensive income (loss) (14,854 ) (4,303 ) Retained earnings (5,791,747 ) (1,408,478 ) Total shareholders' equity 6,640,711 (376,326 ) Total liabilities and stockholders' equity $ 7,440,049 $ 727,851 MEDICINE MAN TECHNOLOGIES, INC.
STATEMENT OF CASH FLOWS
For the Six Months Ended June 30, 2017 and 2016
Expressed in U.S. Dollars
2017 2016 Cash flows from operating activities Net income for the period $ (4,383,271 ) $ (213,518 ) Adjustments to reconcile net income to net cash provided by operating activities Loss (gain) on derivative, net (131,382 ) - S tock based compensation 4,480,318 49,200 Depreciation and amortization 24,822 8,531 Changes in operating assets and liabilities Short term note receivable (14,877 ) (100,000 ) Accounts receivable (230,693 ) 70,447 Inventory (109,174 ) - Other assets (83,085 ) (26,765 ) Accounts payable and other liabilities 99,725 (12,429 ) Net cash used from operating activities (347,617 ) (224,534 ) Cash flows from investing activities Purchase of assets $ (205,890 ) $ - Proceeds from AFS securities, net (10,551 ) - Acquisition investment 233,357 - Net cash earned in investing activities 16,916 - Cash flows from financing activities Cash raised by sale of convertible debt 179,777 - Net cash earned for financing activities 179,777 - Net decrease in cash and cash equivalents $ (150,924 ) $ (224,534 ) Cash and cash equivalents - beginning of year 351,524 262,146 Cash and cash equivalents - end of year $ 200,600 $ 37,612 Non-Cash Transactio ns Acquisition investment $ 233,357 $ - Contact Information: KCSA Strategic Communications MDCL@kcsa.com https://resource.globenewswire.com/Resource/Download/aa6b23a6-0de6-4739-883e-4344e2101fac?size=1
INMG long here... 11 trading days left until MJAC !
Wow! Not to long ago we were about 2 months away from MJAC.. NOW we are ONLY 11 trading days away!! 11!! Go INMG $$$$
Hey 2pot, if your post was deleted and you feel you didnt violate any tos.. you can get it reviewed by ihub admins and possibly restored.. I don't think mods can see why posts were deleted bud..
It's important to know what you own.. good to have you here igster. Good luck to us all.. INMG. Member mark #1 for you $$$$$$$
BOOM! INMG $$$$$$$
Thank you SR!
Folks, Our main focus is INMG here.. stocks go up and stocks go down. That's how it works... I for one, know what I own.. from my DD,I hit the ask bc I believe it's going up.. and if it goes down I try to throw a net at the bid.. it's that simple.. if others disagree, then that's ok.. IMO they ll splat themselves in the butt later
It's ok!! INMG $$$$$$$
SR, INMG is GoinG uP in no time.. you, a few others, and myself know it.. don't let the nobody's get the best of you. It not worth it my friend.. BTW, 2 weeks away until MJAC!!!!! WOOHOO $$$$$
Featuring at the Conference
Innovativ <~~~ TOP of the MJAC list!
HumanityMedicine
MJIC
Invictus-MD
Technical420
Endexx
CVSciences
ORGANIGRAM
AegisBiotech
AurgoraMJ
ChernisLaw
DispensaryPermits
Duard Ventures
Greenrush Consulting
Lexaria Energy
Magical Butter
Mazakali
Team Mary Jane
TMC
Cannliv
CannaNet.tv
Ban-Aid Consulting
PhytoSynthetix
American Growth Fund
Precise Cannabis
Armaplex Security
Hello MD
The Arcview Group
Direct Cannabis Network
Pure Analytics
Supernova Women
Ocean Extracts
High Times
CBMJ
Freedom Leaf
Earth Healthcare
MJAC 2017 is going to be huge for INMG... the share price today will not be the share price come the beginning of september!!!
I know what I own! 2 weeks away!!!
SING and Bitcoin is making moves!! Go SING
It's funny how SING goes up and barely anyone speaks but when it heads down, pump n dump claims are preached lmao too funny. GO SING
I'm scrambling to find more money to buy up more of these cheapies! Ugh. I think I might be missing this dip.. good deal for anyone who picked some up!
Agreed. Go INMG $$
Why would anyone want to walk this stock down , when we all can make $$$ Going up.. smh
Everyday is a good day here on INMG. Some days better than others but happy to be here because I see where we are heading. With a crew like the INMG longs, I'm not worried.. GO INMG $$$$$$$
Great NEWS Everyone!!! The events and news heading our way is going to be epic! Imo If you own INMG, you are in good shape..
The calm before the storm. INMG is set for big moves coming real soon imo. This is going to be Great!!
Guess what??!! INMG is one of the best stocks out there imo ! $$$$$$$
Patience is key. Since 2015, I've seen this stock move and traders come and go. The ones that came and stayed are being rewarded. If not rewarded yet, imo, time will reward you. I've read many different claims on our inmg board, this is the best, this is the worst, it's a pump n dump, it's an investment... there is nothing wrong with being a different type of trader.. IMO seeing is believing and I believe time will continue to reward longs... as long as everyone does there homework on INMG, and they know what they own, the noise will only be noise... Longs are definitely getting stronger imo, and happy to be here longer!! Gltu